← All stocks

Nuvation Bio Inc.

NUVB Scheduled selling only

CIK 0001811063 #1916 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$709.24K

$0.00 on a plan · $709.24K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$709.24K

$0.00 against sales at will

By person

11 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hattersley Gary

CHIEF SCIENTIFIC OFFICER

—

$709.24K (1) scheduled

−$709.24K

0.0000%

$0.00

—

Hung David

PRESIDENT AND CEO

—

59,281,054

16.88%

$420.44M

+1.7%

Wang Junyuan Jerry

CEO, ANHEART THERAPEUTICS LTD.

—

3,866,228

1.10%

$27.42M

−1.4%

Mashal Robert

Director

—

225,000

0.0641%

$1.60M

—

Sjogren Colleen

Chief Commercial Officer

—

81,000

0.0231%

$574.48K

+161.3%

Makunje Moses

SEE REMARKS

—

68,137

0.0194%

$483.25K

+292.1%

Sauvage Philippe

Chief Financial Officer

—

54,131

0.0154%

$383.92K

+692.4%

Wentworth Kerry

CHIEF REGULATORY OFFICER

—

53,000

0.0151%

$375.90K

+1,667%

Markel Stacy

CHIEF PEOPLE OFFICER

—

32,591

0.0093%

$231.15K

+44.3%

Hanley David C.

CHIEF TECHNICAL OPERATIONS

—

24,000

0.0068%

$170.22K

0.0%

Liu Dongfang

CHIEF MEDICAL OFFICER

—

18,000

0.0051%

$127.66K

0.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 100,000

History held since 6 Jul 2020